Your session is about to expire
← Back to Search
Intramuscular Epinephrine for Out-of-Hospital Cardiac Arrest (PRIME Trial)
PRIME Trial Summary
This trial will test whether early intramuscular epinephrine can improve outcomes in pediatric out-of-hospital cardiac arrest.
PRIME Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPRIME Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PRIME Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My child had a cardiac arrest due to a clear injury.My child, aged 17 or younger, had a cardiac arrest outside of a hospital.I received CPR from a trained responder for at least 1 minute.
- Group 1: Standard of Care
- Group 2: Intramuscular Epinephrine Dose
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the primary conditions that this therapy is designed to mitigate?
"Conditions such as hypotension, unresponsive bradycardia, and anisocoria can all be remedied by this proposed intervention."
Are there any available vacancies for participants in this experiment?
"According to the latest information on clinicaltrials.gov, this study is no longer recruiting patients. Although the study is no longer active, there are 105 other trials that are currently looking for candidates."
How many people are allowed to enroll in this research project?
"Unfortunately, this study has already completed recruitment for participants. The listing was first posted on 2023-01-01 but was last edited on 2022-08-15. Although this trial is no longer enrolling patients, there are currently 73 other trials actively recruiting patients with anti-arrhythmia agents and 32 trials for this treatment actively searching for patients."
Can you share if this current study builds off of any previous research?
"At the moment, there are 32 clinical trials underway for this intervention, with 5 of them in Phase 3. Although a few of the research studies are based in San Diego, California, there are 51 total locations running trials for this intervention."
Are the participants in this trial restricted to adults over 18?
"In order to participate in this research, enrollees must be between 1 day to 17 years old. There are currently 16 trials underway for patients that meet this age requirement and 93 for patients that are over 65."
How can I become a part of this experiment?
"Anti-arrhythmia agents are a pre-requisite for potential participants of this study, who must also fall in the age range of 1 day to 17. So far, the trial has recruited 76 individuals."
Share this study with friends
Copy Link
Messenger